BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10971742)

  • 1. Immunopathology of in situ seminoma.
    Bols B; Jensen L; Jensen A; Braendstrup O
    Int J Exp Pathol; 2000 Jun; 81(3):211-7. PubMed ID: 10971742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
    Yakirevich E; Lefel O; Sova Y; Stein A; Cohen O; Izhak OB; Resnick MB
    J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia.
    Hvarness T; Nielsen JE; Almstrup K; Skakkebaek NE; Rajpert-De Meyts E; Claesson MH
    J Reprod Immunol; 2013 Dec; 100(2):135-45. PubMed ID: 24290033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas and Fas-ligand expression in seminomatous testes.
    Braendstrup O; Bols B; Jensen L
    APMIS; 1999 Apr; 107(4):431-6. PubMed ID: 10230699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminoma.
    Grobholz R; Verbeke CS; Schleger C; Köhrmann KU; Hein B; Wolf G; Bleyl U; Spagnoli GC; Coplan K; Kolb D; Iversen K; Jungbluth AA
    Urol Res; 2000 Dec; 28(6):398-403. PubMed ID: 11221919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation.
    Zhao X; Wei YQ; Kariya Y; Teshigawara K; Uchida A
    Immunol Invest; 1995 May; 24(4):607-18. PubMed ID: 7622197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
    Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
    J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between intratubular seminoma and invasive germ cell tumors.
    Berney DM; Lee A; Shamash J; Oliver RT
    Hum Pathol; 2006 Apr; 37(4):458-61. PubMed ID: 16564921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma.
    Sakai Y; Hoshino H; Kitazawa R; Kobayashi M
    Andrology; 2014 Mar; 2(2):282-9. PubMed ID: 24519996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages lysing seminoma cells in patients with carcinoma-in-situ (CIS) of the testis.
    Schütte B; Holstein AF; Schirren C
    Andrologia; 1988; 20(4):295-303. PubMed ID: 3195722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical considerations in the methodology of quantifying immunocompetent cells in tumors.
    Casanova JF; Torres A; Martínez-García F; Hardisson D; Nistal M; Regadera J
    Anal Quant Cytol Histol; 1999 Jun; 21(3):227-34. PubMed ID: 10560495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin binding sites in human seminiferous epithelium, in CIS cells and in seminomas.
    Malmi R; Söderström KO
    Int J Androl; 1987 Feb; 10(1):157-62. PubMed ID: 3583417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Phenotypic Characterisation of Immune Cell Infiltrates in Testicular Germ Cell Neoplasia.
    Richie JP
    J Urol; 2015 Aug; 194(2):396. PubMed ID: 26195368
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report.
    Oosterhuis JW; Kersemaekers AM; Jacobsen GK; Timmer A; Steyerberg EW; Molier M; Van Weeren PC; Stoop H; Looijenga LH
    APMIS; 2003 Jan; 111(1):32-40; discussion 41-2. PubMed ID: 12752231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of immunocompetent cells in testicular germ cell tumours.
    Torres A; Casanova JF; Nistal M; Regadera J
    Histopathology; 1997 Jan; 30(1):23-30. PubMed ID: 9023554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.
    Nouri AM; Hussain RF; Oliver RT; Handy AM; Bartkova I; Bodmer JG
    Eur J Cancer; 1993; 29A(13):1895-9. PubMed ID: 8260249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies.
    Nakanoma T; Nakamura K; Deguchi N; Fujimoto J; Tazaki H; Hata J
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):409-13. PubMed ID: 1455691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax, Bcl-2, fas and Fas-L antigen expression in human seminoma: correlation with the apoptotic index.
    Grobholz R; Zentgraf H; Köhrmann KU; Bleyl U
    APMIS; 2002 Oct; 110(10):724-32. PubMed ID: 12583439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spermatocytic seminoma: views on pathogenesis.
    Müller J; Skakkebaek NE; Parkinson MC
    Int J Androl; 1987 Feb; 10(1):147-56. PubMed ID: 3583416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.